NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 16, 2023

Primary Completion Date

March 14, 2024

Study Completion Date

March 14, 2024

Conditions
PneumoniaAcute PyelonephritisBacteremiaBiliary Tract Infection
Interventions
DIAGNOSTIC_TEST

NGS-based assay for bacterial identification

A total volume of 26ml of whole blood will be sampled from each enrolled patient for three consecutive days. This will be used for Standard-of-Care (SoC) culture and Next Generation Sequencing (NGS), for identification of circulating microorganisms.

Trial Locations (4)

12462

"4th Department of Internal Medicine,Attikon University Hospital, National and Kapodistrian University of Athens, Medical School", Chaïdári

Unknown

1st Department of Internal Medicine, General Hospital of Eleusis THRIASIO, Athens

3rd University Department of Internal Medicine, General Hospital of Chest Diseases of Athens SOTIRIA, Athens

3rd Department of Internal Medicine, General Hospital of Nikaia AGIOS PANTELEIMON, Nikaia

All Listed Sponsors
collaborator

The BioArte

UNKNOWN

lead

Hellenic Institute for the Study of Sepsis

OTHER

NCT06141395 - NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification | Biotech Hunter | Biotech Hunter